Sivalingam VN, et al. Diagnosis and management of ectopic pregnancy. J Fam Plann Reprod Health Care. 2011;37(4):231–40.
Article PubMed PubMed Central Google Scholar
Bouyer J, et al. Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases. Hum Reprod. 2002;17(12):3224–30.
Article CAS PubMed Google Scholar
Di SpiezioSardo A, et al. Combined systemic and hysteroscopic intra-amniotic injection of methotrexate associated with hysteroscopic resection for cervical pregnancy: a cutting-edge approach for an uncommon condition. Eurasian J Med. 2017;49(1):66–8.
Garzon S, et al. Laparoscopic reversible occlusion of uterine arteries and cornuostomy for advanced interstitial pregnancy. Minim Invasive Ther Allied Technol. 2019;28(6):359–62.
Marion LL, Meeks GR. Ectopic pregnancy: history, incidence, epidemiology, and risk factors. Clin Obstet Gynecol. 2012;55(2):376–86.
Lee R, et al. Diagnosing ectopic pregnancy in the emergency setting. Ultrasonography. 2018;37(1):78.
Van Mello NM, et al. Ectopic pregnancy: how the diagnostic and therapeutic management has changed. Fertil Steril. 2012;98(5):1066–73.
Samal SK, Rathod S. Cervical ectopic pregnancy. J Natural Sci Biol Med. 2015;6(1):257.
Article PubMed PubMed Central Google Scholar
Rezaei Z, et al. The effective role of adding letrozole to methotrexate in the management of tubal ectopic pregnancies, a randomized clinical trial. Iranian Journal of Pharmaceutical Research: IJPR. 2021;20(4):378.
CAS PubMed PubMed Central Google Scholar
Alabiad MA, et al. Evaluation of different doses of the aromatase inhibitor letrozole for the treatment of ectopic pregnancy and its effect on villous trophoblastic tissue. Reprod Sci. 2022;29(10):2983–94.
Article CAS PubMed Google Scholar
Mitwally MF, et al. Aromatase inhibitor letrozole: a novel treatment for ectopic pregnancy. Fertil Steril. 2020;114(2):361–6.
Article CAS PubMed Google Scholar
Garcia-Velasco JA, et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril. 2005;84(1):82–7.
Article CAS PubMed Google Scholar
Gurates B, et al. Treatment of symptomatic uterine leiomyoma with letrozole. Reprod Biomed Online. 2008;17(4):569–74.
Article CAS PubMed Google Scholar
Kashani BN, et al. Role of medical management for uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol. 2016;34:85–103.
Franik, S., et al., Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews, 2018;5.
Ferrero S, et al. Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial. Reprod Biol Endocrinol. 2011;9(1):1–7.
Nash CM, et al. Letrozole pretreatment prior to medical termination of pregnancy: a systematic review. Contraception. 2018;97(6):504–9.
Article CAS PubMed Google Scholar
Zhuo Y, et al. The efficacy of letrozole supplementation for medical abortion: a meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2021;34(9):1501–7.
Article CAS PubMed Google Scholar
Palomba S. Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab. 2015;100(5):1742–7.
Article CAS PubMed Google Scholar
Moons KG, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014;11(10):e1001744.
Article PubMed PubMed Central Google Scholar
Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):1–11.
Shi, J., et al., Detecting the skewness of data from the sample size and the five-number summary. arXiv preprint arXiv:2010.05749, 2020.
Shi J, et al. Optimally estimating the sample standard deviation from the five-number summary. Research Synthesis Methods. 2020;11(5):641–54.
Luo D, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–805.
Wan X, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.
Article PubMed PubMed Central Google Scholar
Mokhatri-Hesari P, Montazeri A. Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018. Health Qual Life Outcomes. 2020;18(1):338.
El-Sayed AN, Sultan MA, Taha ESM. Compared study between the use of ietrozole and methotrexate for the medical treatment of early suspecious undisturbed tubal ectopic pregnancy. Al-Azhar Med J. 2022;51(2):851–60. https://doi.org/10.21608/amj.2022.230453.
Eltohamy MM, Abdelrahman AA, Elmasarawy AH, Elbeheidy TM. The aromatase inhibitor “letrozole” versus methotrexate for management of undisturbed ectopic pregnancy. J Cardiovasc Dis Res. 2021;12(05):476.
Mazhar BS, Aftab S, Asif M. Letrozole: a novel medical treatment of ectopic pregnancy: case report. Bjog-an Int J Obstet Gynaecol. 2021.
Kochhar N, Reena, Prateek S, Chawla L. Resolution of chronic ectopic pregnancy with letrozole. Int J Clinic Obst Gynaecol. 2021;5(1):341–2. https://doi.org/10.33545/gynae.2021.v5.i1f.834.
Baggio S, Garzon S, Russo A, Ianniciello CQ, Santi L, Laganà AS, Raffaelli R, Franchi M. Fertility and reproductive outcome after tubal ectopic pregnancy: comparison among methotrexate, surgery and expectant management. Arch Gynecol Obstet. 2021;303(1):259–68. https://doi.org/10.1007/s00404-020-05749-2.
Article CAS PubMed Google Scholar
Canis M, et al. Ectopic pregnancy: criteria to decide between medical and conservative surgical treatment? J Gynecol Obstet Biol Reprod (Paris). 2003;32(7 Suppl):S54-63.
Practice Committee of the American Society for Reproductive Medicine. Medical treatment of ectopic pregnancy: a committee opinion. Fertil Steril. 2013;100(3):638–44.
Tiboni G, et al. Impact of estrogen replacement on letrozole-induced embryopathic effects. Hum Reprod. 2009;24(11):2688–92.
Article CAS PubMed Google Scholar
Yeung TWY, et al. A pilot study on the use of a 7-day course of letrozole followed by misoprostol for the termination of early pregnancy up to 63 days. Contraception. 2012;86(6):763–9.
Article CAS PubMed Google Scholar
Aydin M, et al. Letrozole induces hepatotoxicity without causing oxidative stress: the protective effect of melatonin. Gynecol Endocrinol. 2011;27(4):209–15.
Article CAS PubMed Google Scholar
Mukherjee AG, Wanjari UR, Nagarajan D, K K V, V A, Paul P J, Priya T, Chakraborty R, Renu K, Dey A, Vellingiri B, Gopalakrishnan AV. Letrozole: pharmacology, toxicity and potential therapeutic effects. Life Sci. 2022;310:121074. https://doi.org/10.1016/j.lfs.2022.121074.
Comments (0)